VENTYX BIOSCIENCES INC (VTYX) Stock Income Statement
NASDAQ:VTYX - Nasdaq - US92332V1070 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 136.78M | 148.45M | 207.69M | 113.14M | 67.15M | |||
| Research and Development | 106.15M | 117.00M | 175.57M | 87.74M | 58.48M | |||
| Selling, General, and Administrative Expenses | 30.63M | 31.45M | 32.13M | 25.40M | 8.67M | |||
| Operating Income | -136.78M | -148.45M | -207.69M | -113.14M | -67.15M | |||
| Interest Income/Expense | 12.86M | 13.42M | 15.07M | 4.67M | -100.00K | |||
| Other Income/Expense | -66.00K | -88.00K | -42.00K | 40.00K | -16.50M | |||
| Non Recurring Items | N/A | N/A | -300.00K | N/A | N/A | |||
| Income Before Taxes | -123.99M | -135.12M | -192.96M | -108.43M | -83.75M | |||
| Net Income | -123.99M | -135.12M | -192.96M | -108.43M | -85.30M | |||
| EBITDA | -135.15M | -147.10M | -206.75M | -113.02M | -67.12M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.75 | -1.97 | -3.30 | -2.07 | -1.69 | |||
| Non GAAP EPS | -1.75 | -1.98 | -3.30 | -2.05 | N/A | |||
| Statistics | ||||||||
All data in USD